tetano
Editor, Senior Moderator
Clin Infect Dis
. 2025 Mar 24:ciaf148.
doi: 10.1093/cid/ciaf148. Online ahead of print. Use of baloxavir marboxil post-exposure prophylaxis to halt an influenza A(H3) outbreak in a college sports team, November 2024
Noah Kojima[SUP] 1 [/SUP], Annabelle de St Maurice[SUP] 2 [/SUP], Earl J Erezo[SUP] 1 [/SUP], Erika Yanez[SUP] 1 [/SUP], Elizabeth Traub[SUP] 2 [/SUP], Allison Joyce[SUP] 2 [/SUP], Amy Marutani[SUP] 3 [/SUP], Nicole Green[SUP] 3 [/SUP], Sharon Balter[SUP] 2 [/SUP], Sheree R Poitier[SUP] 1 [/SUP], Jan King[SUP] 1 [/SUP]
Affiliations
Baloxavir marboxil is approved for influenza treatment and post-exposure prophylaxis (PEP). There are limited real world examples of its use in influenza outbreaks. Here, we describe the use of Baloxavir marboxil as PEP to halt an influenza outbreak among a student athlete sports team during the 2024-2025 influenza season.
Keywords: Baloxavir; Influenza; Influenza post-exposure prophylaxis; Outbreak.
. 2025 Mar 24:ciaf148.
doi: 10.1093/cid/ciaf148. Online ahead of print. Use of baloxavir marboxil post-exposure prophylaxis to halt an influenza A(H3) outbreak in a college sports team, November 2024
Noah Kojima[SUP] 1 [/SUP], Annabelle de St Maurice[SUP] 2 [/SUP], Earl J Erezo[SUP] 1 [/SUP], Erika Yanez[SUP] 1 [/SUP], Elizabeth Traub[SUP] 2 [/SUP], Allison Joyce[SUP] 2 [/SUP], Amy Marutani[SUP] 3 [/SUP], Nicole Green[SUP] 3 [/SUP], Sharon Balter[SUP] 2 [/SUP], Sheree R Poitier[SUP] 1 [/SUP], Jan King[SUP] 1 [/SUP]
Affiliations
- PMID: 40127195
- DOI: 10.1093/cid/ciaf148
Baloxavir marboxil is approved for influenza treatment and post-exposure prophylaxis (PEP). There are limited real world examples of its use in influenza outbreaks. Here, we describe the use of Baloxavir marboxil as PEP to halt an influenza outbreak among a student athlete sports team during the 2024-2025 influenza season.
Keywords: Baloxavir; Influenza; Influenza post-exposure prophylaxis; Outbreak.